BIO-key International, Inc. (BKYI)
NASDAQ: BKYI · Real-Time Price · USD
5.00
-0.31 (-5.86%)
Jul 9, 2026, 4:00 PM EDT - Market closed
BIO-key International Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 2.69 | 0.44 | 0.51 | 2.64 | 7.75 |
Cash & Short-Term Investments | 2.69 | 0.44 | 0.51 | 2.64 | 7.75 |
Cash Growth | 515.78% | -14.43% | -80.60% | -66.01% | -55.71% |
Accounts Receivable | 1.24 | 0.72 | 1.2 | 1.52 | 0.97 |
Other Receivables | - | 0.07 | 0.1 | 0.05 | 0.13 |
Total Trade Receivables | 1.24 | 0.79 | 1.3 | 1.57 | 1.1 |
Inventory | 0.37 | 0.38 | 0.45 | 4.43 | 4.94 |
Other Current Assets | 0.29 | 0.28 | 0.36 | 0.34 | 0.26 |
Total Current Assets | 4.6 | 1.89 | 2.62 | 8.98 | 14.01 |
Net Property, Plant & Equipment | 0.12 | 0.21 | 0.26 | 0.3 | 0.32 |
Other Intangible Assets | 0.83 | 1.1 | 1.41 | 1.76 | 1.3 |
Goodwill | - | - | - | - | 1.26 |
Long-Term Investments | 5 | 5 | - | - | 0.45 |
Other Long-Term Assets | 0.32 | 0.42 | 0.23 | 0.29 | 0.37 |
Total Assets | 10.87 | 8.62 | 4.52 | 11.34 | 17.77 |
Accounts Payable | 0.52 | 0.82 | 1.32 | 1.11 | 0.43 |
Accrued Expenses | 1.32 | 1.28 | 1.31 | 1.01 | 0.83 |
Short-Term Debt | 0.6 | 1.53 | - | - | - |
Current Portion of Long-Term Debt | 0.05 | 0.13 | 0.14 | 0.12 | - |
Current Portion of Leases | 0.03 | 0.02 | 0.04 | 0.16 | 0.18 |
Unearned Revenue | 0.57 | 0.77 | 0.41 | 0.46 | 0.57 |
Total Current Liabilities | 3.1 | 4.55 | 3.21 | 5.46 | 2 |
Long-Term Debt | - | 0.04 | 0.19 | 2.92 | - |
Long-Term Leases | 0.02 | 0.05 | - | 0.04 | 0.09 |
Other Long-Term Liabilities | 0.08 | 0.2 | 0.05 | 0.22 | 0.07 |
Total Long-Term Liabilities | 0.1 | 0.29 | 0.24 | 0.59 | 0.15 |
Total Liabilities | 3.2 | 4.84 | 3.45 | 6.04 | 2.15 |
Common Stock | 0 | 0 | 0 | 0 | 0 |
Additional Paid-in Capital | 141.5 | 133.03 | 126.05 | 122.03 | 120.19 |
Accumulated Other Comprehensive Income | 0.07 | 0.05 | 0.02 | -0.24 | - |
Retained Earnings | - | -129.31 | -125.01 | -116.49 | -104.58 |
Shareholders' Equity | 141.57 | 3.77 | 1.06 | 5.3 | 15.62 |
Total Liabilities & Equity | 144.76 | 8.62 | 4.52 | 11.34 | 17.77 |
Total Debt | 0.7 | 1.78 | 0.37 | 3.24 | 0.26 |
Net Cash (Debt) | 1.99 | -1.34 | 0.15 | -0.6 | 7.49 |
Net Cash Growth | - | - | - | - | -55.35% |
Net Cash Per Share | 3.00 | -6.50 | 2.61 | -13.85 | 173.03 |
Book Value | 141.57 | 3.77 | 1.06 | 5.3 | 15.62 |
Book Value Per Share | 212.96 | 18.31 | 18.98 | 121.37 | 360.74 |
Tangible Book Value | 140.74 | 2.67 | -0.34 | 3.54 | 13.05 |
Tangible Book Value Per Share | 211.71 | 12.98 | -6.15 | 81.01 | 301.58 |